Skip to content

In the BioHarmony Drug Report Database

Flecainide

Tambocor (flecainide) is a small molecule pharmaceutical. Flecainide was first approved as Tambocor on 1985-10-31. It is used to treat atrial fibrillation, cardiac arrhythmias, supraventricular tachycardia, and ventricular tachycardia in the USA. It is known to target potassium voltage-gated channel subfamily A member 7, potassium voltage-gated channel subfamily A member 1, potassium voltage-gated channel subfamily A member 5, potassium voltage-gated channel subfamily C member 1, and potassium voltage-gated channel subfamily A member 2.
Trade Name Tambocor
Common Name Flecainide
Indication atrial fibrillation, cardiac arrhythmias, supraventricular tachycardia, ventricular tachycardia
Drug Class Ic antiarrhythmic
Flecainide
Get full access now